Therapeutic Drug Monitoring of Gentamicin in Patients with Bronchopneumonia: Cost Considerations and Patient Outcomes

Therapeutic Drug Monitoring of Gentamicin in Patients with Bronchopneumonia: Cost Considerations and Patient Outcomes

Objective: In Malaysia, therapeutic drug monitoring (TDM) service started in the late 1980s. Serum concentration measurements depend on commercially available drug assays, which are costly. In the present study, we attempted to document the impact of TDM service on cost and patient outcomes. Materia...

Full description

Bibliographic Details
Main Authors: Hisham Elhag Ahmed Abdelrahim, Ab Fatah Ab Rahman, Mohamad Izham Mohamed Ibrahim
Format: Article
Language:English
Published: AVES 2012-04-01
Series:Eurasian Journal of Medicine
Subjects:
Bronchopneumonia
Cost evaluation
Malaysia
Patient outcome
Therapeutic drug monitoring
Online Access:http://www.eajm.org/text.php3?id=420

Similar Items

Similar Items